2021-04-15T09:10:18Z
2021-04-15T09:10:18Z
2020-06-27
2021-04-15T09:10:18Z
Organic and biological compounds (especially those related to the pharmaceutical industry) have always been of great interest for researchers due to their importance for the development of new drugs to diagnose, cure, treat or prevent disease. As many new API (active pharmaceutical ingredients) and their polymorphs are in nanocrystalline or in amorphous form blended with amorphous polymeric matrix (known as amorphous solid dispersion-ASD), their structural identification and characterization at nm scale with conventional X-Ray/Raman/IR techniques becomes difficult. During any API synthesis/production or in the formulated drug product, impurities must be identified and characterized. Electron energy loss spectroscopy (EELS) at high energy resolution by transmission electron microscope (TEM) is expected to be a promising technique to screen and identify the different (organic) compounds used in a typical pharmaceutical or biological system and to detect any impurities present, if any, during the synthesis or formulation process. In this work, we propose the use of monochromated TEM-EELS, to analyze selected peptides and organic compounds and their polymorphs. In order to validate EELS for fingerprinting (in low loss/optical region) and by further correlation with advanced DFT, simulations were utilized.
Artículo
Versión publicada
Inglés
Indústria farmacèutica; Daltonisme; Pharmaceutical industry; Color blindness
MDPI
Reproducció del document publicat a: https://doi.org/10.3390/polym12071434
Polymers, 2020, vol. 12, num. 7, p. 1434
https://doi.org/10.3390/polym12071434
info:eu-repo/grantAgreement/EC/H2020/731019/EU//EUSMI
cc-by (c) Das, Partha Pratim et al., 2020
http://creativecommons.org/licenses/by/3.0/es